Contaminated Cough syrup tragedy: Sresen Pharma owner remanded in 10-day police custody
- byDoctor News Daily Team
- 11 October, 2025
- 0 Comments
- 0 Mins

Chhindwara:The owner of a Tamil Nadu-based pharma company, Sresen Pharma, was remanded in 10-day police custody by a court on Friday after being linked to the tragic deaths of over 20 children in Madhya Pradesh. Ranganathan Govindan, whose company manufactured the contaminated Coldrifcough syrup, was arrested by a Special Investigative Team (SIT) set up by the MP government. Govindan was brought before Additional Session Judge Gautam Gurjar in Parasia town after he was brought on transit remand from a Chennai court, SIT chief Jitendra Jaat said. The court has remanded Ranganathan Govindan in 10-day police remand, Jaat told PTI. Additional collector Dhirendra Singh Netri maintained that so far 22 children have died because of "contaminated" Coldrif syrup. These children, from Chhindwara and other districts, died due to suspected kidney failure, which is linked to the consumption of 'toxic' Coldrif cough syrup, as per officials, adding that some children from the state are undergoing treatment in Nagpur in neighbouring Maharashtra. The factory in which the cough syrup was manufactured has been sealed, Jaat added. In action related to the episode, which has made national headlines, the Mohan Yadav government earlier this week suspended two drug inspectors and a deputy director of the Food and Drug Administration (FDA). It also transferred the state's drug controller amid an investigation into the children's deaths, while police arrested Chhindwara-based Dr Praveen Soni for alleged negligence. Soni's bail plea was rejected on Wednesday by a court in Parasia. Incidentally, the Indian Medical Association has opposed the arrest of Dr Soni and its members have sported black bands in protest.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Mumbai's GT Hospital doctor injured after ceiling...
- 20 October, 2025
Rajasthan HC Quashes Ban on New B.Pharm Colleges,...
- 20 October, 2025
Dr. Reddy's Labs Gets CDSCO Panel Nod to Manufactu...
- 20 October, 2025
CDSCO Panel Rejects Pure and Cure's Empagliflozin-...
- 20 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!